Sun Pharmaceutical Industries Ltd said it will buy Ranbaxy Laboratories Ltd in a $3.2 billion all-share deal, creating the world's fifth-largest generic drug maker. Under terms of the agreed deal, Ranbaxy shareholders will get 0.8 of a Sun Pharmaceutical share for each Ranbaxy share they own. Notably, Ranbaxy is India's biggest drugmaker by sales.